Hava specializes in the fields of organic chemistry, medicinal chemistry, pharmaceuticals (including new chemical entities, processes for manufacturing, second medical use, formulations), inorganic chemistry, nanotechnology, medical devices, food industry, fibers, compounds in agriculture, industrial machinery in the field of environmental science and preservation of materials.
Hava has vast experience in drafting, prosecution, litigation and due diligence processes. Hava represents and advises clients ranging from seed startup companies, international pharmaceutical companies, venture capital funds and university technology transfer units.
Hava received her Ph.D. in 2005 from the Hebrew University of Jerusalem in Organic Chemistry. Her Ph.D. thesis was directed to Chiral Switches, single-enantiomer drugs derived from established racemates. She was admitted to practice before the Israeli Patent Office in 2008.